Search

everythinglearnresearchcommunity

for

Search:↓

New topical antifungals and delivery systems are improving treatment for fungal skin infections, but patient education and prevention are key.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Low iron levels are not directly linked to chronic hair loss and iron supplements may not help.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Fat tissue cells are a promising option for healing various diseases, but more research is needed to ensure they are safe and effective.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

Trichoscopy is a quick, noninvasive method to diagnose hair and scalp disorders, often reducing the need for biopsies.

Some chemotherapy can cause permanent hair loss.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

PEGL-DOX causes Hand-Foot Syndrome due to skin reactions from prolonged circulation and ROS generation.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

LED therapy is safe and shows potential for treating skin conditions and promoting hair growth, but more research is needed.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Low-level laser therapy is safe and can increase hair growth for male and female pattern hair loss.

Zinc can both inhibit and stimulate mouse hair growth, and might help recover hair after chemotherapy.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.